ArticleAmerican journal of ophthalmology2015

Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial.

Emily Y Chew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.